An article published on PubMed.gov, Dec. 2011, describes a 40-year old woman with Pompe Disease who successfully carried a healthy baby to term. She continued to receive enzyme replacement therapy (ERT) with alglucosidase alfa. There were no maternal complications and the child developed normally. One year after delivery the mother’s physical condition was similar as prior to her pregnancy.
advocacy awards Awareness business CAP chaperone clinical trials compassion CORD COVID-19 eLearning Emma Rooney ERT Extraordinary Measures Fabry FDA fundraising Gaucher gene therapy getting treated grants guest blogger IND Int'l Pompe Day IPA late-onset law living with Pompe meetings Muscular Dystrophy Canada MyNormal newborn screening NIH Orphan Drug Framework Orphanet politics portraits pre-clinical preclinical pregnancy privacy Rare Disease Rare Disease Day research video